Verdad Advisers »

Proqr Thrapeutics N V shs euro shares owned by Verdad Advisers

Quarter-by-quarter ownership of Proqr Thrapeutics N V shs euro (PRQR) shares owned by Verdad Advisers from 13F filings

Historical chart of Verdad Advisers investment in Proqr Thrapeutics N V shs euro

Tip: Access up to 7 years of quarterly data

All positions including Proqr Thrapeutics N V shs euro held by Verdad Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Proqr Thrapeutics N V shs euro by Verdad Advisers

Quarter filed Position value Share count Share price at filing
2026-06-30 $36k 19k 1.86

More positions owned by Verdad Advisers

Apple (AAPL)
Belite Bio Sponsored Ads (BLTE)
ACADIA Pharmaceuticals (ACAD)
Comcast Corp Cl A (CMCSA)
Chatham Lodging Trust (CLDT)
Tenax Therapeutics Com New (TENX)
Slide Ins Hldgs (SLDE)
Zymeworks Del (ZYME)
AMN Healthcare Services (AMN)
X4 Pharmaceuticals Com New (XFOR)
Versant Media Group Com Cl A (VSNT)
NetScout Systems (NTCT)
Aadi Bioscience (WHWK)
Johnson & Johnson (JNJ)
Contineum Therapeutics Cl A (CTNM)

View all positions for Verdad Advisers

Top funds holding Proqr Thrapeutics N V shs euro

Adage Capital Partners GP
Standard Life Aberdeen
Affinity Asset Advisors
Privium Fund Management B.V.
Ikarian Capital
Woodline Partners
Heights Capital Management
Sphera Funds Management
Kynam Capital Management
DAFNA Capital Management
Squadron Capital Management
683 Capital Management
Morgan Stanley
Citadel Advisors
Platinum Investment Mangement

View all funds holding Proqr Thrapeutics N V shs euro